APPLICATION
ANDA205191
TYPE
ANDA
ORIGINAL APPROVAL
2018-11-15
LATEST ACTION
2024-03-29
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued
Products
KETOROLAC TROMETHAMINEDiscontinued
KETOROLAC TROMETHAMINE 0.4% · SOLUTION/DROPS · OPHTHALMIC
Approval history
2024-03-29Labeling · Supplement 2 · standardAP
2018-11-15UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.